- Home
- NUVB vs MTUS Comparison
NUVB vs MTUS Comparison
Compare NUVB & MTUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- MTUS
- Stock Information
- Founded
- NUVB 2018
- MTUS 1899
- Country
- NUVB United States
- MTUS United States
- Employees
- NUVB N/A
- MTUS N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- MTUS
- Sector
- NUVB Health Care
- MTUS
- Exchange
- NUVB Nasdaq
- MTUS NYSE
- Market Cap
- NUVB 679.9M
- MTUS 707.3M
- IPO Year
- NUVB N/A
- MTUS N/A
- Fundamental
- Price
- NUVB $2.50
- MTUS $16.99
- Analyst Decision
- NUVB Strong Buy
- MTUS
- Analyst Count
- NUVB 6
- MTUS 0
- Target Price
- NUVB $7.83
- MTUS N/A
- AVG Volume (30 Days)
- NUVB 5.9M
- MTUS 353.3K
- Earning Date
- NUVB 08-04-2025
- MTUS 08-07-2025
- Dividend Yield
- NUVB N/A
- MTUS N/A
- EPS Growth
- NUVB N/A
- MTUS N/A
- EPS
- NUVB N/A
- MTUS N/A
- Revenue
- NUVB $10,957,000.00
- MTUS $1,042,900,000.00
- Revenue This Year
- NUVB $98.78
- MTUS $8.76
- Revenue Next Year
- NUVB $489.71
- MTUS $8.74
- P/E Ratio
- NUVB N/A
- MTUS N/A
- Revenue Growth
- NUVB N/A
- MTUS N/A
- 52 Week Low
- NUVB $1.54
- MTUS $10.78
- 52 Week High
- NUVB $3.97
- MTUS $22.78
- Technical
- Relative Strength Index (RSI)
- NUVB 63.18
- MTUS 62.42
- Support Level
- NUVB $2.06
- MTUS $15.64
- Resistance Level
- NUVB $2.62
- MTUS $18.17
- Average True Range (ATR)
- NUVB 0.15
- MTUS 0.50
- MACD
- NUVB 0.04
- MTUS 0.02
- Stochastic Oscillator
- NUVB 78.71
- MTUS 53.36
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About MTUS METALLUS INC
Metallus Inc is an America-based manufacturer of alloy steel, as well as carbon and micro-alloy steel. The portfolio of the company includes special bar quality steel, seamless mechanical tubes, and value-add solutions, such as precision steel components. The company also supplies machining and thermal treatment services and manages raw material recycling programs that work as a feeder system for its melt operations. The company's products and services are used in the following sectors: oil and gas; automotive; industrial equipment; mining; construction; rail; aerospace and defense; heavy truck; agriculture and power generation. Geographically, the company mainly serves customers in the United States.